December Newsmakers

Duke RadOnc Christmas
Our LINACs are radiating with holiday cheer! Duke Radiation Oncology has some very creative Radiation Therapists


Lifetime Achievement Award Winner Dr. Keith Sullivan Reflects on His Career and Passion (Nucleus-- ASTCT)
Features Keith Sullivan, MD

Teen's cancer uncovers a mystery in one North Carolina town: Why here? (NBC News)
Features Heather Stapleton, PhD

Researchers Investigate Cancer Clusters In North Carolina (NPR Morning Edition/WRVO)

FDA Approves Enzalutamide for Metastatic Castration-Sensitive Prostate Cancer (OncLive)
Features Andrew Armstrong, MD

Is it Feasible to Change the Immunotherapy Dose Schedule for a Patient in Complete Response? (HemeOnc Today)
Features April Salama, MD

Enzalutamide Plus ADT Significantly Reduces Risk of Progression in Metastatic Hormone-Sensitive Prostate Cancer (Targeted Oncology)
Features Andrew Armstrong

Your Flame-Resistant Tent Could Give You Cancer (Outside)
Heather Stapleton, PhD

Health Beat: Cutting-edge chemo delivery for colorectal cancer (WFMZ-TV), (NBCDFW) (WNDU)
Features Michael Lidsky, MD

New metastatic breast cancer research initiative announced (WRAL TV)
Features Duke Cancer Institute

One Billion Dollar Gift To Be Shared By Duke, MIT, USC And The Cleveland Clinic (Forbes)
Features Duke University

Many Surgeons Shy Away From Breast Cancer Cost Discussions (General Surgery News)
Features Rachel A. Greenup, MD, MPH

Duke Research Could Be a Big Deal for Cancer Vaccines (Triangle Business Journal)

THE SILENT WARRIORS: Symptoms began in June for Patrick Henry coach Tommy Thomas, followed by cancer diagnosis on July 11 (Bristol Herald Courier)
Features Allan Friedman, MD

Study Suggests Patients with Ovarian Cancer Will Accept Higher Risk of Complications for Better OS (Oncology)
Features Laura Havrilesky, MD

Duke Researchers Show How Stem Cell Mutations Arise and Metastasize in the Colon (Clinical OMICS)
Features Joshua Snyder, PhD

Clinical Phenotypes of Prostate Cancer and Prognostic Factors (OncLive)
Features Daniel George, MD

Prostate Cancer: PSA-DT and Initiating AR-Targeted Therapy (OncLive)
Features Daniel George, MD

FDA advisory committee unanimously supports approval of tazemetostat for epithelioid sarcoma (HemOnc Today)
Features Richard Riedel, MD

FDA Panel Split on PARP Inhibitor for Pancreatic Cancer (MedPage Today)
Features Anthony Sung, MD

2019 Best Doctors (Business North Carolina)
Features Nelson Chao, MD; Carlos de Castro, MD; Louis Diehl, MD; Harry Erba, MD, PhD; David Rizzieri, MD

WATCH: Radiation After Breast Cancer Diagnosis (OncologyTube)
Features Lola Fayanju, MD, MA, MPHS

LISTEN: Cancer Evolution and Comparative Oncology with Dr. Jason Somarelli and Dr. Will Eward (EvolutionaryMD)
Features Jason Somarelli, PhD, and Will Eward, DVM, MD

Francis named new chair of Department of Head and Neck Surgery & Communication Sciences (Duke SoM)
Features Howard W. Francis, MD

Dr. Jennifer Plichta Appointed to the Editorial Board for Breast Cancer Research (Duke Surgery)
Features Jennifer Plichta, MD

Dr. Beasley Receives DCI Award for Poliovirus in Melanoma Research (Duke Surgery)
Features Georgia Beasley, MD

Cervical Cancer Screening, HPV Vaccinations Improved through Technologies and Initiatives (Clinical Practice Today)
Features Megan J. Huchko, MD, MPH

MoDukes Fundraise $40,000 for Movember (Duke Prostate & Urologic Cancer Center)

Fighting to Eliminate Cervical Cancer (Duke Global Health Institute)
Features Megan Huchko, MD


Individualizing systemic therapy for advanced soft tissue sarcomas based on tumor histology and biology. Expert Review of Anticancer Therapy. Dec. 20, 2019. Candace L Haddox, Richard Riedel.

A Case-control Study Examining Disparities in Clinical Trial Participation among Breast Surgical Oncology Patients. JNCI Cancer Spectrum. Dec. 16, 2019. Oluwadamilola M Fayanju, MD, MA, MPHS, Yi Ren, MS, Samantha M Thomas, MS, Rachel A Greenup, MD, MPH, Terry Hyslop, PhD, E Shelley Hwang, MD, MPH, John H Stewart, IV, MD, MBA.

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer. New England Journal of Medicine. Dec. 11, 2019. Rashmi K. Murthy, M.D., Sherene Loi, M.D., Alicia Okines, M.D., Elisavet Paplomata, M.D., Erika Hamilton, M.D., Sara A. Hurvitz, M.D., Nancy U. Lin, M.D., Virginia Borges, M.D., Vandana Abramson, M.D., Carey Anders, M.D., Philippe L. Bedard, M.D., Mafalda Oliveira, M.D., Erik Jakobsen, M.D., Thomas Bachelot, M.D., Shlomit S. Shachar, M.D., Volkmar Müller, M.D., Sofia Braga, M.D., Francois P. Duhoux, M.D., Richard Greil, M.D., David Cameron, M.D., Lisa A. Carey, M.D., Giuseppe Curigliano, M.D., Ph.D., Karen Gelmon, M.D., Gabriel Hortobagyi, M.D., Ian Krop, M.D., Ph.D., Sibylle Loibl, M.D., Mark Pegram, M.D., Dennis Slamon, M.D., M. Corinna Palanca-Wessels, M.D., Ph.D., Luke Walker, M.D., Wentao Feng, Ph.D., and Eric P. Winer, M.D.

Hiding in Plain Sight. JAMA. Dec. 10, 2019. Oluwadamilola “Lola” M. Fayanju, MD, MA, MPHS.

Exercise and Patients With Cancer—Is It Time to Get Heavier With the Dose? JAMA. Dec. 5, 2019. Colin E. Champ, MD, CSCS; William S. Yancy Jr, MD.

Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Science Translational Medicine. Dec. 4, 2019. Yanjing Li, Yiping He, William Butler, Lingfan Xu,Yan Chang, Kefeng Lei, Hong Zhang, Yinglu Zhou, Allen C. Gao, Qingfu Zhang, Daniel G. Taylor, Donghui Cheng, Suzette Farber-Katz, Rachid Karam, Tyler Landrith, Bing Li, Sitao Wu, Vickie Hsuan, Qing Yang, Hailiang Hu, Xufeng Chen, Melissa Flowers, Shannon J. McCall, John K. Lee, Bryan A. Smith, Jung Wook Park, Andrew S. Goldstein, Owen N. Witte, Qianben Wang, Matthew B. Rettig, Andrew J. Armstrong, Qing Cheng, and Jiaoti Huang.

Integration of Palliative Care into Acute Myeloid Leukemia Care. Seminars in Oncology Nursing. Dec. 2019. Jason A.Webb,MD, FAPA, FAAHPM;Thomas W.LeBlanc, MD, MA, MHS, FAAHPM; Areej R.El-Jawahri, MD.

291 Increasing Lengths of First Complete Remission with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia over the Past Four Decades: Analysis of SWOG Trial Data. (poster/abstract) ASH Annual Meeting. Dec. 7, 2019. Megan Othus, PhD, Guillermo Garcia-Manero, MD, John E. Godwin, MD, James K. Weick, MD, Frederick R. Appelbaum, MD, Harry P. Erba, MD, PhD, and Elihu H. Estey, MD.

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort. Journal of Thoracic Oncology. July 30, 2019. Neal E. Ready, MD, PhD; Patrick A. Ott, MD, PhD; Matthew D. Hellmann, MD; Jon Zugazagoitia, MD, PhD; Christine L. Hann, MD, PhD; Filippo de Braud, MD; Scott J. Antonia, MD, PhD; Paolo A. Ascierto, MD; Victor Moreno, MD, PhD; Akin Atmaca, MD; Stefania Salvagni, MD; Matthew Taylor, MD; Asim Amin, MD, PhD; D. Ross Camidge, MD, PhD; Leora Horn, MD, MSc; Emiliano Calvo, MD, PhD; Ang Li, MS; Wen Hong Lin, MD, MSc; Margaret K. Callahan, MD, PhD; David R. Spigel, MD.

Acute Presentation of Previously Unrecognized Congenital Ureteropelvic Junction Obstruction 5 Weeks After Radical Retropubic Prostatectomy. Urology. August 14, 2019. Shelby N. Harper, Laura P.Hale, Michael N. Ferrandino, Judd W. Moul.